Select your language

Adobe Stock

07.03.2025

2024: A year in review

The year 2024 has been remarkable in the fields of tuberculosis and non-tuberculous mycobacteria (NTM) diseases.

 

The Tuberculosis Network European Trialsgroup (www.tbnet.eu) offers a concise YEAR IN REVIEW of the peer reviewed published scientific literature of 2024. The review covers clinically relevant publications on the epidemiology, prevention, diagnosis and treatment of tuberculosis in children and adults and on diseases caused by non-tuberculous mycobacteria. It lists the best publications, the important new WHO recommendations and provides an algorithm for the treatment of drug-resistant tuberculosis based on latest WHO management guidelines.

“A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists”

is a comprehensive resource for everyone who wished to be updated on the latest developments in tuberculosis and NTM diseases and is available as an open access publication.

Reference:

Lange C, Bothamley G, Günther G, Guglielmetti L, Kontsevaya I, Kuksa L, Lange B, Lorent N, Saluzzo F, Sester M, Tebruegge M, Tunesi S, Tweed C, for the Tuberculosis Network European Trialsgroup (TBnet). A year in review on tuberculosis and non-tuberculous mycobacteria disease: A 2025 update for clinicians and scientists. Path Immun. 2025 https://doi.org/10.20411/pai.v10i2.791

 

Contact

Stefan Niemann

Prof. Dr. med. Dr. h.c. Christoph Lange

DZIF TTU TB (ClinTB)
T +49 4537 / 188-3010 (Sekretariat)
F +49 4537 / 188-6030
clange@fz-borstel.de


 
 

2025           2024           2023           2022